Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (51-60 of 274) with videos related to

Pageof 28
Sort By:
Seminars in Pediatric Neurology|October 16, 1999
A 13-year-old with an acute change in mental statusB E Gidal, J N Seltz, P Rutecki
Seizure|March 26, 2018
Time course of reversal of valproate-mediated inhibition of lamotrigineEmili Leary, Raj D Sheth, Barry E Gidal
Therapeutic Drug Monitoring|March 19, 2013
Assessing impact of real-world dosing irregularities with lamotrigine extended-release and immediate-release formulations by pharmacokinetic simulationChao Chen, James Wright, Barry Gidal, et al.
Epilepsy Currents|October 28, 2014
Cannabidiol: promise and pitfallsTimothy E Welty, Adrienne Luebke, Barry E Gidal
Epilepsy Research|April 13, 2005
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trialsBarry E Gidal, Eugène Baltès, Christian Otoul, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Pharmacologic management of epilepsy in the elderlyS V Bourdet, B E Gidal, B K Alldredge
Pharmacotherapy|July 3, 1999
The ketogenic diet. Central Nervous System Practice and Research Network of the American College of Clinical PharmacyJ L Bainbridge, B E Gidal, M Ryan
Epilepsy & Behavior : E&B|July 10, 2023
Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?Barry E Gidal, Rizwana Rehman, Tung Tran, et al.
The Annals of Pharmacotherapy|January 1, 1993
Apparent valproic acid neurotoxicity in a hypoalbuminemic patientB E Gidal, D M Collins, B R Beinlich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 1995
Immunotherapy in multiple sclerosis, Part 1C C Becker, B E Gidal, J O Fleming
Pageof 28

Showing results (51-60 of 274) with videos related to

Sort By:
Pageof 28
Seminars in Pediatric Neurology|October 16, 1999
A 13-year-old with an acute change in mental statusB E Gidal, J N Seltz, P Rutecki
Seizure|March 26, 2018
Time course of reversal of valproate-mediated inhibition of lamotrigineEmili Leary, Raj D Sheth, Barry E Gidal
Therapeutic Drug Monitoring|March 19, 2013
Assessing impact of real-world dosing irregularities with lamotrigine extended-release and immediate-release formulations by pharmacokinetic simulationChao Chen, James Wright, Barry Gidal, et al.
Epilepsy Currents|October 28, 2014
Cannabidiol: promise and pitfallsTimothy E Welty, Adrienne Luebke, Barry E Gidal
Epilepsy Research|April 13, 2005
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trialsBarry E Gidal, Eugène Baltès, Christian Otoul, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Pharmacologic management of epilepsy in the elderlyS V Bourdet, B E Gidal, B K Alldredge
Pharmacotherapy|July 3, 1999
The ketogenic diet. Central Nervous System Practice and Research Network of the American College of Clinical PharmacyJ L Bainbridge, B E Gidal, M Ryan
Epilepsy & Behavior : E&B|July 10, 2023
Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?Barry E Gidal, Rizwana Rehman, Tung Tran, et al.
The Annals of Pharmacotherapy|January 1, 1993
Apparent valproic acid neurotoxicity in a hypoalbuminemic patientB E Gidal, D M Collins, B R Beinlich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 1995
Immunotherapy in multiple sclerosis, Part 1C C Becker, B E Gidal, J O Fleming
Pageof 28